Clinical utility of cytomegalovirus viral load in solid organ transplant recipients

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current Opinion in Infectious Diseases

• Publication date

  2015-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QCO.0000000000000173PMID 26098497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small bowel transplantation complicated by cytomegalovirus tissue invasive disease without viremia.

  2014cited by this paper
• Detection of human cytomegalovirus in transbronchial biopsies from lung transplant recipients

  2013cited by this paper
• Clinical Utility of Viral Load in Management of Cytomegalovirus Infection after Solid Organ Transplantation

  2013cited by this paper
• Cytomegalovirus in Solid Organ Transplantation

  2013cited by this paper
• Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients

  2013cited by this paper
• Conversion to the COBAS AmpliPrep/COBAS TaqMan CMV Test for management of CMV disease in transplant recipients.

  2013cited by this paper
• Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.

  2013cited by this paper
• Prospective study on CMV-reactivations under preemptive strategy in CMV-seropositive adult liver transplant recipients.

  2013cited by this paper
• Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients.

  2013cited by this paper
• Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection.

  2013cited by this paper
• High Incidence of Anticytomegalovirus Drug Resistance Among D+R− Kidney Transplant Recipients Receiving Preemptive Therapy

  2012cited by this paper
• Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay.

  2012cited by this paper
• An International Multicenter Performance Analysis of Cytomegalovirus Load Tests

  2012cited by this paper
• Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy

  2012cited by this paper
• Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial

  2012cited by this paper
• The Clinical Utility of Whole Blood Versus Plasma Cytomegalovirus Viral Load Assays for Monitoring Therapeutic Response

  2011cited by this paper
• Factors Contributing to Variability of Quantitative Viral PCR Results in Proficiency Testing Samples: a Multivariate Analysis

  2011cited by this paper
• Direct and indirect effects of cytomegalovirus: can we prevent them?

  2010cited by this paper
• Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients

  2010cited by this paper
• CMV PCR as a diagnostic tool for CMV gastrointestinal disease after solid organ transplantation.

  2010cited by this paper
• Interlaboratory Comparison of Cytomegalovirus Viral Load Assays

  2009cited by this paper
• Clinical features and outcomes of cytomegalovirus retinitis after transplantation

  2008cited by this paper
• Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

  2007cited by this paper
• Prediction of Cytomegalovirus (CMV) Plasma Load from Evaluation of CMV Whole-Blood Load in Samples from Renal Transplant Recipients

  2007cited by this paper
• Cytomegalovirus viremia in solid organ transplantation: does the initial viral load correlate with risk factors and outcomes?

  2007cited by this paper
• Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients

  2006cited by this paper
• Clinical Utility of Cytomegalovirus Viral Load in Bronchoalveolar Lavage in Lung Transplant Recipients

  2005cited by this paper
• Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.

  2004cited by this paper
• Correlation between Viral Loads of Cytomegalovirus in Blood and Bronchoalveolar Lavage Specimens from Lung Transplant Recipients Determined by Histology and Immunohistochemistry

  2004cited by this paper
• Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real‐time quantitative DNA PCR assay: Correlation with pp67 RNA detection

  2004cited by this paper
• Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

  2002cited by this paper
• Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease.

  2002cited by this paper
• The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease.

  2002cited by this paper
• Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.

  2000cited by this paper
• Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation.

  2000cited by this paper
• A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients.

  1995cited by this paper

• Determinación de un cut-off de carga viral para terapia anticipada en receptores de trasplante hepático con riesgo intermedio para Citomegalovirus

  2025cites this paper
• T‐lymphocyte subtyping: an early warning and a potential prognostic indicator of active cytomegalovirus infection in patients with sepsis

  2022cites this paper
• Cytomegalovirus Viremia in Solid-Organ Transplant Patients in the First Year After Transplantation.

  2022cites this paper
• Cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: clinical significance and definitions

  2022cites this paper
• Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation

  2022cites this paper
• Belatacept may result in profound and persistent loss of cytomegalovirus‐specific cell‐mediated immunity: A case report

  2022cites this paper
• T-Lymphocyte Subtyping: A Potential Diagnostic and Prognostic Indicator of Cytomegalovirus Infection in Sepsis Patients

  2021cites this paper
• Case Report: Next-Generation Sequencing in Diagnosis of Pneumonia Due to Pneumocystis jirovecii and Cytomegalovirus in a Patient With HIV Infection

  2021cites this paper
• Cytomegalovirus in Lung Transplant

  2021cites this paper
• Frequency of Cytomegalovirus Seropositivity and Viremia in a Midwestern University Lupus Population.

  2020cites this paper
• Companion and complementary diagnostics for infectious diseases

  2020cites this paper
• Antibody neutralization and its determinants in HIV-1 infected patients from Portugal: implications for vaccine design and efficacy

  2019cites this paper
• Altered human cytomegalovirus-encoded miRNAs in host circulation: novel disease biomarkers and potential aetiological agents

  2019cites this paper
• CMV infection management in transplant patients in Italy.

  2019cites this paper
• Impact of cytomegalovirus load on host response to sepsis

  2019cites this paper
• Cytomegalovirus Infection: comparison of methodologies for monitoring renal and cardiac transplants

  2019influential citation
• Predictive factors of spontaneous CMV DNAemia clearance in kidney transplantation.

  2018cites this paper
• The effect of anti‐thymocyte globulin and everolimus on the kinetics of cytomegalovirus viral load in seropositive kidney transplant recipients without prophylaxis

  2018cites this paper
• Cytomegalovirus glycoprotein types and disease causation

  2018cites this paper
• Standardization of Viral Load Determination for Monitoring CMV, EBV, and BK Viruses in Solid Organ Transplant Recipients

  2018cites this paper
• Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey

  2017cites this paper
• Consolidation of molecular testing in clinical virology

  2017cites this paper
• Practical Aspects of Cytomegalovirus DNA Quantitative PCR

  2017cites this paper
• Inclusions or bystanders? CMV PCR sensitivity and specificity in tissue samples.

  2017cites this paper
• Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis

  2016cites this paper
• Virology: The Next Generation from Digital PCR to Single Virion Genomics

  2015cites this paper